Prantesh Jain

1.1k total citations
46 papers, 626 citations indexed

About

Prantesh Jain is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Prantesh Jain has authored 46 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Prantesh Jain's work include Lung Cancer Research Studies (13 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Prantesh Jain is often cited by papers focused on Lung Cancer Research Studies (13 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Prantesh Jain collaborates with scholars based in United States, United Kingdom and Canada. Prantesh Jain's co-authors include Vamsidhar Velcheti, Mohammadhadi Khorrami, Anant Madabhushi, Kaustav Bera, Mehdi Alilou, Avirup Guha, Pradnya D. Patil, Afshin Dowlati, Amit Gupta and Jahir M. Gutierrez and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Prantesh Jain

42 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prantesh Jain United States 14 382 255 187 107 69 46 626
Silvia Girolama Drago Italy 9 252 0.7× 187 0.7× 391 2.1× 72 0.7× 36 0.5× 16 623
Felipe Couñago Spain 16 325 0.9× 477 1.9× 218 1.2× 100 0.9× 37 0.5× 110 812
Keisuke Tamari Japan 16 203 0.5× 242 0.9× 162 0.9× 159 1.5× 74 1.1× 72 676
Anastasios Dimou United States 16 481 1.3× 311 1.2× 71 0.4× 201 1.9× 56 0.8× 67 800
Seung Yeun Chung South Korea 14 155 0.4× 159 0.6× 194 1.0× 30 0.3× 52 0.8× 31 537
Shikai Wu China 18 461 1.2× 284 1.1× 85 0.5× 159 1.5× 97 1.4× 73 796
Maren Knödler Germany 10 228 0.6× 175 0.7× 89 0.5× 115 1.1× 37 0.5× 19 535
Robert H. Siegelbaum United States 12 296 0.8× 246 1.0× 231 1.2× 31 0.3× 51 0.7× 23 747
Sophie Marguet France 8 395 1.0× 402 1.6× 123 0.7× 86 0.8× 108 1.6× 12 806
F. Cachin France 15 180 0.5× 137 0.5× 294 1.6× 112 1.0× 30 0.4× 70 716

Countries citing papers authored by Prantesh Jain

Since Specialization
Citations

This map shows the geographic impact of Prantesh Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prantesh Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prantesh Jain more than expected).

Fields of papers citing papers by Prantesh Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prantesh Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prantesh Jain. The network helps show where Prantesh Jain may publish in the future.

Co-authorship network of co-authors of Prantesh Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Prantesh Jain. A scholar is included among the top collaborators of Prantesh Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prantesh Jain. Prantesh Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beltran, Himisha, Prantesh Jain, Erin L. Schenk, et al.. (2025). 2758MO Updated results from a phase I/II study of gocatamig for small cell lung cancer (SCLC) and other neuroendocrine cancers. Annals of Oncology. 36. S1367–S1367.
2.
3.
Liang, E. W., Yan Li, Shipra Gandhi, et al.. (2024). Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors. JCO Oncology Practice. 21(3). 408–417. 4 indexed citations
4.
Choudhury, Noura J., Himisha Beltran, Erin L. Schenk, et al.. (2024). OA10.06 Impact of Brain Metastases on Safety and Efficacy of MK-6070, a DLL3-Targeting T Cell Engager, in Small Cell Lung Cancer. Journal of Thoracic Oncology. 19(10). S32–S33. 4 indexed citations
5.
Smith, Randall J., Eric Kannisto, Prantesh Jain, et al.. (2024). Obesity-specific improvement of lung cancer outcomes and immunotherapy efficacy with metformin. JNCI Journal of the National Cancer Institute. 117(4). 673–684. 4 indexed citations
6.
Perimbeti, Stuthi, Kristopher Attwood, Hongbin Chen, et al.. (2024). Patients' Preferences for Adjuvant Osimertinib in Non–Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?. Clinical Lung Cancer. 25(6). 509–518. 2 indexed citations
7.
8.
9.
Braman, Nathaniel, Prateek Prasanna, Kaustav Bera, et al.. (2022). Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers. Clinical Cancer Research. 28(20). 4410–4424. 19 indexed citations
10.
Jain, Prantesh, et al.. (2021). Nasopharyngeal neuroendocrine neoplasms: Systematic review of the literature and case presentation. Journal of Neuroendocrinology. 33(8). e13005–e13005. 3 indexed citations
11.
Jain, Prantesh, Jahir M. Gutierrez, Avirup Guha, et al.. (2021). Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States. ESMO Open. 6(5). 100252–100252. 43 indexed citations
12.
Guha, Avirup, César Caraballo, Prantesh Jain, et al.. (2021). Outcomes in Patients with Anthracycline-Induced Cardiomyopathy Undergoing Left Ventricular Assist Devices Implantation. ESC Heart Failure. 8(4). 2866–2875. 11 indexed citations
13.
Guha, Avirup, Sadeer Al‐Kindi, Prantesh Jain, et al.. (2020). Association between myocarditis and other immune‐related adverse events secondary to immune checkpoint inhibitor use. International Journal of Cancer. 147(6). 1753–1754. 13 indexed citations
14.
Jain, Prantesh, Yu‐Wei Chen, Bhumika Patel, et al.. (2019). Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting. Research and Practice in Thrombosis and Haemostasis. 3(2). 226–233. 13 indexed citations
15.
Khorrami, Mohammadhadi, Prantesh Jain, Kaustav Bera, et al.. (2019). Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features. Lung Cancer. 135. 1–9. 56 indexed citations
16.
Patil, Pradnya D., Kaustav Bera, Pranjal Vaidya, et al.. (2018). P2.04-17 Pre-Therapy Radiomic Features Can Distinguish Hyperprogression from Other Response Patterns to PD1/PD-L1 Inhibitors in NSCLC. Journal of Thoracic Oncology. 13(10). S737–S737. 2 indexed citations
17.
Khunger, Monica, Prantesh Jain, Sagar Rakshit, et al.. (2018). Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Clinical Lung Cancer. 19(3). e335–e348. 45 indexed citations
18.
Jain, Prantesh, et al.. (2014). Isolated Zinc Deficiency Causing Severe Microcytosis and Sideroblastic Anemia. Turkish Journal of Hematology. 31(3). 339–341. 2 indexed citations
19.
Gupta, Shweta, et al.. (2013). Very High Alpha-Fetoprotein (Afp): a Poor Prognostic Indicator in Hepatocellular Carcinoma in the Modern Era. Annals of Oncology. 24. iv67–iv67. 2 indexed citations
20.
Gupta, Shweta, et al.. (2012). 5-flourouracil (5FU) shortage: Clinical implications and costs in a single month.. Journal of Clinical Oncology. 30(4_suppl). 663–663. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Girolama Drago Breakdown of academic impact, for papers by Felipe Couñago Breakdown of academic impact, for papers by Keisuke Tamari Breakdown of academic impact, for papers by Anastasios Dimou Breakdown of academic impact, for papers by Seung Yeun Chung Breakdown of academic impact, for papers by Shikai Wu Breakdown of academic impact, for papers by Maren Knödler Breakdown of academic impact, for papers by Robert H. Siegelbaum Breakdown of academic impact, for papers by Sophie Marguet Breakdown of academic impact, for papers by F. Cachin
Rankless by CCL
2026